BCWM
GILD icon

Ball & Co Wealth Management’s Gilead Sciences GILD Stock Holding History

Ball & Co Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$964K Buy
7,636
+49
+0.6% +$6.46K 0.68% 14
2026
Q1 		$1.06M Buy
7,587
+45
+0.6% +$6.3K 0.88% 11
2025
Q4 		$925K Buy
7,542
+48
+0.6% +$5.83K 0.6% 16
2025
Q3 		$831K Buy
7,494
+53
+0.7% +$6.02K 0.55% 16
2025
Q2 		$825K Buy
7,441
+54
+0.7% +$5.75K 0.88% 9
2025
Q1 		$827K Buy
7,387
+52
+0.7% +$5.37K 0.89% 10
2024
Q4 		$677K Buy
+7,335
New +$660K 0.54% 12

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ball & Co Wealth Management's GILD Position: Q2 2026 in Review

Ball & Co Wealth Management increased its Gilead Sciences (GILD) stake by 0.65% in Q2 2026, buying an estimated $6.46K and bringing the position to 7,636 shares worth $964K. The position accounts for 0.68% of the portfolio, ranked #14.

Ball & Co Wealth Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.06M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Ball & Co Wealth Management held 7,636 shares of Gilead Sciences worth $964K as of Q2 2026.
  • Ball & Co Wealth Management bought 49 Gilead Sciences shares in Q2 2026, an estimated $6.46K.
  • Gilead Sciences made up 0.68% of Ball & Co Wealth Management's portfolio in Q2 2026, its #14 holding.
  • Ball & Co Wealth Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Ball & Co Wealth Management's Gilead Sciences position peaked at $1.06M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Ball & Co Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.